Literature DB >> 9407475

Using interpersonal psychotherapy (IPT) in a combined psychotherapy/medication research protocol with depressed elders. A descriptive report with case vignettes.

M D Miller1, L Wolfson, E Frank, C Cornes, R Silberman, L Ehrenpreis, J Zaltman, J Malloy, C F Reynolds.   

Abstract

One hundred eighty subjects at least 60 years of age with recurrent unipolar major depression were recruited to participate in a depression treatment protocol. All patients received drug therapy with nortriptyline (NT) and interpersonal psychotherapy (IPT) with an experienced clinician. Acutely, 81% of subjects showed a full response to combined treatment. In the initial 127 subjects, the most common problem areas in therapy were role transition (41%), interpersonal disputes (34.5%), and grief (23%). Case vignettes are presented and discussed. The combination of IPT and NT showed a powerful antidepressant effect. IPT was readily adaptable to the needs of depressed elders.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9407475      PMCID: PMC3330480     

Source DB:  PubMed          Journal:  J Psychother Pract Res        ISSN: 1055-050X


  16 in total

1.  Psychotherapy of aged persons. II. Utilization and effectiveness of brief therapy.

Authors:  A I GOLDFARB; H TURNER
Journal:  Am J Psychiatry       Date:  1953-06       Impact factor: 18.112

2.  Three-year outcomes for maintenance therapies in recurrent depression.

Authors:  E Frank; D J Kupfer; J M Perel; C Cornes; D B Jarrett; A G Mallinger; M E Thase; A B McEachran; V J Grochocinski
Journal:  Arch Gen Psychiatry       Date:  1990-12

3.  Opportunities for psychotherapy in the management of dementia.

Authors:  M D Miller
Journal:  J Geriatr Psychiatry Neurol       Date:  1989 Jan-Mar       Impact factor: 2.680

4.  The transference of the therapist of the elderly.

Authors:  H Muslin; S Clarke
Journal:  J Am Acad Psychoanal       Date:  1988-07

Review 5.  Psychodynamic considerations of aging and the aged: an overview.

Authors:  M A Berezin
Journal:  Am J Psychiatry       Date:  1972-06       Impact factor: 18.112

6.  Psychotherapy for geriatric patients.

Authors:  S L Safirstein
Journal:  N Y State J Med       Date:  1972-11-15

Review 7.  Toward a clinical model of psychotherapy for depression, I: Systematic comparison of three psychotherapies.

Authors:  T B Karasu
Journal:  Am J Psychiatry       Date:  1990-02       Impact factor: 18.112

8.  Applying interpersonal psychotherapy to bereavement-related depression following loss of a spouse in late life.

Authors:  M D Miller; E Frank; C Cornes; S D Imber; B Anderson; L Ehrenpreis; J Malloy; R Silberman; L Wolfson; J Zaltman; C F Reynolds
Journal:  J Psychother Pract Res       Date:  1994

9.  Psychodynamics and aging.

Authors:  D A Wasylenki
Journal:  Can J Psychiatry       Date:  1982-02       Impact factor: 4.356

10.  National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments.

Authors:  I Elkin; M T Shea; J T Watkins; S D Imber; S M Sotsky; J F Collins; D R Glass; P A Pilkonis; W R Leber; J P Docherty
Journal:  Arch Gen Psychiatry       Date:  1989-11
View more
  4 in total

1.  Depression in Parkinson's Disease.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  2000-05       Impact factor: 3.598

Review 2.  Recognition and treatment of dysthymia in elderly patients.

Authors:  S Bellino; F Bogetto; P Vaschetto; S Ziero; L Ravizza
Journal:  Drugs Aging       Date:  2000-02       Impact factor: 3.923

Review 3.  Antidepressants and psychotherapy: a clinical research review.

Authors:  Ellen Frank; Danielle Novick; David J Kupfer
Journal:  Dialogues Clin Neurosci       Date:  2005       Impact factor: 5.986

4.  Interpersonal psychotherapy (IPT) for late-life depression in general practice: uptake and satisfaction by patients, therapists and physicians.

Authors:  Digna J F van Schaik; Harm W J van Marwijk; Aartjan T F Beekman; Marten de Haan; Richard van Dyck
Journal:  BMC Fam Pract       Date:  2007-09-13       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.